Americans stretching Rxs to save money

12 January 2009

More than 13.5 million Americans, equivalent to over 20% of US adults who use long-term prescribed medication (including those taking  injectables), in the last three months have taken steps to stretch out  their medicine, either by reducing the dosage or taking it less often  than prescribed, according to a survey by market research firm  ICR/International Communications Research.

Even about one in 10 patients who need critical therapy that must be  injected by a health professional have found ways to stretch out these  often very expensive, doctor-recommended prescriptions. Overall, for  injectables, the percentage of patients who indicated doing this in the  last three months ranges from 9% for those administered by a health care  professional, to 22% for self-injected drugs like insulin for diabetics.  Issues of overall cost and the recent financial climate, including  factors relating to insurance coverage and medication co-pay, were cited  most often as the reasons why people have begun trying to make their  prescriptions last longer.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight